Oireachtas Joint and Select Committees

Wednesday, 12 July 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion

9:00 am

Mr. Shaun Flanagan:

We are flagging that there is an EU process called EUnetHTA which has been in place for around a decade. It has struggled to standardise this scientifically. If one is doing a cost benefit analysis one has to consider the benefit and the costs. We may pay our clinicians and nurses differently to how Germany does. That all builds in to the cost benefit analysis. The Deputy can shake his head, but that is the actual truth.